Developmental pathway of the MPER-Directed HIV-1-Neutralizing antibody 10E8

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Soto, Cinque ^a   Ofek, Gilad ^a   Joyce, M Gordon ^a   Zhang, Baoshan ^a   McKee, Krisha ^a   Longo, Nancy S ^a   Yang, Yongping ^a   Huang, Jinghe ^a   Parks, Robert ^b   Eudailey, Joshua ^b   Lloyd, Krissey E ^b   Alam, S Munir ^b   Haynes, Barton F ^b   Mullikin, James C ^c   Connors, Mark ^a   Mascola, John R ^a   Shapiro, Lawrence ^a,d   Kwong, Peter D ^a   NISC Comparative Sequencing Program, ^e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; NEUTRALIZING ANTIBODY; NEUTRALIZING ANTIBODY 10E8; UNCLASSIFIED DRUG; COMPLEMENTARITY DETERMINING REGION; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; PROTEIN EXPRESSION; PYROSEQUENCING; SEQUENCE ALIGNMENT; SOMATIC MUTATION; STOP CODON; VALIDATION PROCESS; VIRUS NEUTRALIZATION; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOLECULAR MODEL; MUTAGENESIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; CELL LINE; COMPLEMENTARITY DETERMINING REGIONS; CRYSTALLOGRAPHY, X-RAY; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; MUTAGENESIS;

EID: 84976349128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157409     Document Type: Article

References (39)

1. Hraber P, Seaman MS, Bailer RT, Mascola JR, Montefiori DC, et al. (2014) Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection. AIDS 28: 163-169. doi: 10.1097/QAD.0000000000000106 PMID: 24361678
2. Liu J, Yue J, Wu S, Yan Y (2007) Polymorphisms and drug resistance analysis of HIV-1 CRF01-AE strains circulating in Fujian Province, China. Arch Virol 152: 1799-1805. PMID: 17619115
3. Haynes BF, Kelsoe G, Harrison SC, Kepler TB (2012) B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nature biotechnology 30: 423-433. doi: 10.1038/nbt.2197 PMID: 22565972
4. Jardine J, Julien JP, Menis S, Ota T, Kalyuzhniy O, et al. (2013) Rational HIV immunogen design to target specific germline B cell receptors. Science 340: 711-716. doi: 10.1126/science.1234150 PMID: 23539181
5. Liao HX, Lynch R, Zhou T, Gao F, Alam SM, et al. (2013) Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496: 469-476. doi: 10.1038/nature12053 PMID: 23552890
6. Bonsignori M, Zhou T, Sheng Z, Chen L, Gao F, et al. (2016) Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody. Cell 165: 449-463. doi: 10.1016/j.cell.2016.02.022 PMID: 26949186
7. Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, et al. (2014) Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509: 55-62. doi: 10.1038/nature13036 PMID: 24590074
8. Huang J, Ofek G, Laub L, Louder MK, Doria-Rose N, et al. (2012) Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491: 406-+. doi: 10.1038/nature11544 PMID: 23151583
9. Muster T, Steindl F, Purtscher M, Trkola A, Klima A, et al. (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67: 6642-6647. PMID: 7692082
10. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, et al. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 78: 10724-10737. PMID: 15367639
11. Julien JP, Bryson S, Nieva JL, Pai EF (2008) Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anionbinding site. J Mol Biol 384: 377-392. doi: 10.1016/j.jmb.2008.09.024 PMID: 18824005
12. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, et al. (2001) Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 75: 10892-10905. PMID: 11602729
13. Muster T, Guinea R, Trkola A, Purtscher M, Klima A, et al. (1994) Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J Virol 68: 4031-4034. PMID: 7514684
14. Zhu Z, Qin HR, Chen W, Zhao Q, Shen X, et al. (2011) Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J Virol 85: 11401-11408. doi: 10. 1128/JVI.05312-11 PMID: 21880764
15. Ofek G, Zirkle B, Yang Y, Zhu Z, McKee K, et al. (2014) Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6. J Virol 88: 2426-2441. doi: 10.1128/JVI.02837-13 PMID: 24335316
16. Julien JP, Huarte N, Maeso R, Taneva SG, Cunningham A, et al. (2010) Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding. J Virol 84: 4136-4147. doi: 10.1128/JVI.02357-09 PMID: 20147404
17. Chen J, Frey G, Peng H, Rits-Volloch S, Garrity J, et al. (2014) Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. J Virol 88: 1249-1258. doi: 10.1128/JVI. 02664-13 PMID: 24227838
18. Zhu J, Ofek G, Yang Y, Zhang B, Louder MK, et al. (2013) Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc Natl Acad Sci U S A 110: 6470-6475. doi: 10.1073/pnas.1219320110 PMID: 23536288
19. Haynes BF, Fleming J, St Clair EW, Katinger H, Stiegler G, et al. (2005) Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308: 1906-1908. PMID: 15860590
20. Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, et al. (2006) A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 203: 393-400. PMID: 16446381
21. Huang J, Ofek G, Laub L, Louder MK, Doria-Rose NA, et al. (2012) Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491: 406-412. doi: 10.1038/nature11544 PMID: 23151583
22. Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, et al. (2010) Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01. Science 329: 811-817. doi: 10.1126/science.1192819 PMID: 20616231
23. Majeed S, Ofek G, Belachew A, Huang CC, Zhou T, et al. (2003) Enhancing protein crystallization through precipitant synergy. Structure 11: 1061-1070. PMID: 12962625
24. Otwinowski Z, Minor Wladek (1997) Processing of X-ray diffraction data collected in oscillation model. Methods in Enzymology 276: 307-326.
25. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674. PMID: 19461840
26. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221. doi: 10.1107/S0907444909052925 PMID: 20124702
27. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501. doi: 10.1107/S0907444910007493 PMID: 20383002
28. Davis IW, Murray LW, Richardson JS, Richardson DC (2004) MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res 32: W615-619. PMID: 15215462
29. DeLano WL (2002) The PyMOL Molecular Graphics System. San Carlos, CA: DeLano Scientific.
30. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, et al. (2011) Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333: 1593-1602. doi: 10.1126/science.1207532 PMID: 21835983
31. Ye J, Ma N, Madden TL, Ostell JM (2013) IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res 41: W34-40. doi: 10.1093/nar/gkt382 PMID: 23671333
32. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948. PMID: 17846036
33. Aouinti S, Malouche D, Giudicelli V, Kossida S, Lefranc MP (2015) IMGT/HighV-QUEST Statistical Significance of IMGT Clonotype (AA) Diversity per Gene for Standardized Comparisons of Next Generation Sequencing Immunoprofiles of Immunoglobulins and T Cell Receptors. PLoS One 10: e0142353. doi: 10.1371/journal.pone.0142353 PMID: 26540440
34. Felsenstein J (1989) PHYLIP-Phylogeny Inference Package (Version 3.2). Cladistics 5: 164-166.
35. Huson DH, Scornavacca C (2012) Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks. Syst Biol 61: 1061-1067. doi: 10.1093/sysbio/sys062 PMID: 22780991
36. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C (1991) Sequences of Proteins of Immunological Interest: U.S. Department of Health and Human Service, National Institutes of Health, Bethesda MD.
37. Ofek G, Guenaga FJ, Schief WR, Skinner J, Baker D, et al. (2010) Elicitation of structure-specific antibodies by epitope scaffolds. Proc Natl Acad Sci U S A 107: 17880-17887. doi: 10.1073/pnas.1004728107 PMID: 20876137
38. Sok D, Laserson U, Laserson J, Liu Y, Vigneault F, et al. (2013) The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. PLoS Pathog 9: e1003754. doi: 10.1371/journal.ppat.1003754 PMID: 24278016
39. Bhiman JN, Anthony C, Doria-Rose NA, Karimanzira O, Schramm CA, et al. (2015) Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat Med 21: 1332-1336. doi: 10.1038/nm.3963 PMID: 26457756